Spectral pattern recognition analysis of in vivo spectroscopic data was performed to predict histopathological tumour grade astrocytomas. Analysis of the spectral pattern of biochemical changes detected by 1HMRS significantly improved non-invasive tumour grading.
UrenjakJWilliamsSR: Specific expression of N-acetylaspartate in neurons oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro: J Neurochem59: 55–61, 1992.
2.
BhakooKKLandH: Phosphorylcholine: A putative marker of cancer. Differential regulation of choline metabolites during oncogenic transformation. Proc Soc Mangn Reson Med6: 69, 1996.
3.
KueselACDonnellySM: Mobile Lipids and metabolic heterogeneity of brain tumors as detectable by ex vivo 1HMR spectroscopy. NMR Biomed7: 172–180, 1994.
4.
KueselACSutherlandGR: 1HMR spectroscopy of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue. NMR Biomed7: 149–155, 1994.
5.
NegendankWGSauterR: Proton magnetic resonance spectroscopy in patients with glial tumors: A multicenter study. J Neurosurg84: 449–458, 1996.
6.
AlgerJRFrankJA: Metabolism of human gliomas: Assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology177: 633–641, 1990.
7.
SomorjaiRLKitchenD: How to discriminate between high and low grade astrocytomas of human brain neoplasm: Robust multivariant analysis of 1H MR spectra. Proc Soc Magn Reson Med5: 1939, 1995.
8.
CarpinelliGCarapellaCM: Differentiation of glioblastoma multiforme from astrocytomas by in vitro 1H MRS analysis of human brain tumors. Anticancer Res16: 1559–1564, 1996.
9.
DeanBLDrayerBP: Gliomas: Classification with MR imaging. Radiology174: 411–415, 1987.
10.
StackJPAntounNM: Gadolinium-DTPAas a contrast agent in magnetic resonnce imaging of the brain. Neuroradiology30: 145–154, 1988.
11.
KonziolkaDLandsfordLDMartinezAJ: Unreliability of contemorary neurodiagnostic imaging in evaluating suspected adult supratentorial (low grade) astrocytoma. J Neurosurg79: 533–536, 1993.
12.
Di ChiroGDe la PazRL: Glucose utilization of cerebral gliomas measured by 18F fluorodeoxyglucose and positron emission tomography. Neurology32: 1323–1329, 1982.
13.
Di ChiroG: Positron emission tomography using 18F fluoro deoxyglucose in brain tumors a powerful diagnostic and prognostic tool. Invest Radiol22: 360–371, 1986.
